Clinical trials
Anemia, Refractory, with Excess of Blasts trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| ALZA | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Maastricht University | 1 |
| Patrick Stiff | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Providence Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 15 |
| Myelodysplastic Syndromes | 11 |
| Anemia, Refractory | 6 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.